1 Min Read
April 26 (Reuters) - Biopharmx Corp:
* BIOPHARMX REPORTS FOURTH QUARTER AND FULL YEAR 2018 FINANCIAL RESULTS
* Q4 NON-GAAP LOSS PER SHARE $0.03 EXCLUDING ITEMS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.